A well-functioning supply chain ensures that high-quality malaria prevention and treatment services are successful. MSH helps to strengthen the supply chain for malaria commodities at all levels, from global markets to private medicine vendors and down to frontline community health workers. We help global agencies, national governments, and local stakeholders make the best use of resources and adopt policies to preserve the efficacy of effective antimalarial drugs. MSH works to improve the capacity of ministries of health to deliver appropriate treatments by providing technical assistance in policy design, supply chain management, drug efficacy and safety, and quality control. Our work has helped to improve the availability and use of antimalarial medicines and diagnostics in more than 30 countries.
Policy Design and Implementation
MSH works with all levels of the health system to design and implement effective malaria treatment and prevention policies. At the national level, we facilitate partner coordination to build consensus on prevention and treatment strategies for malaria and other infectious disease, including the development of standard treatment guidelines, essential medicines lists, and standard operating procedures. In partnership with regulatory bodies, we work to strengthen antimalarial product controls for improved safety and efficacy. In facilities and communities, MSH facilitates the transition and roll-out of national-level guidelines for ACT, RDTs, and injectable artesunate for the treatment of severe malaria.
Supply Chain Management
In partnership with key stakeholders at the national, regional, and facility levels, MSH develops effective pharmaceutical forecasting and requisitioning systems and improved drug storage techniques. Our field teams help ministries procure essential medicines and commodities and improve management information systems to facilitate accurate data on product availability, consumption, and pricing. MSH’s tools and training courses equip health workers to assess pharmaceutical management systems for malaria commodities, and these assessments are then used to inform evidence-based interventions.
Quality Control and Drug Safety
MSH provides technical assistance to ensure the quality of antimalarial drugs and tests by implementing interventions focused on:
Detecting and removing substandard and counterfeit products from the market
Facilitating batch testing of RDTs according to WHO’s recommendations
Improving the quality of laboratory diagnosis
MSH partners with national drug regulatory agencies to ensure drug safety by monitoring adverse drug events. In addition, we partner with RBM, the Global Fund, the Gates Foundation, UNITAID, PMI, and other organizations to ensure a safe, effective, and consistent malaria pharmaceutical and diagnostic commodities supply chain.